BWXT BWXT
Company Profile ↓Company Overview
BWXT (BWXT) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 26.7%, reflecting efficient use of shareholder capital.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $3.20B (+18.3% YoY); net profit $328.94M.
- Trailing 12 Months Year-on-year growth — revenue +18.3%, earnings +16.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.2%, profit CAGR 5.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.16% |
| 1 Year: | 18.30% |
Compounded Profit Growth
| 5 Years: | 5.86% |
| 1 Year: | 16.67% |
Stock Price Performance
| 1 Year: | +9.52% |
| 6 Months: | -19.98% |
| 3 Months: | -18.26% |
| 1 Month: | -9.57% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)41.53 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 26.7%.
- Generates positive free cash flow.
CONS
- Trading 29.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 428.23M | 410.01M | 419.36M | 430.14M | 457.46M | 438.92M | 425.51M | 478.00M | 416.45M | 471.23M | 506.00M | 501.24M | 542.21M | 504.52M | 519.88M | 556.91M | 528.27M | 505.10M | 498.73M | 591.98M | 530.74M | 554.21M | 523.71M | 624.18M | 568.36M | 612.45M | 589.99M | 725.51M | 603.97M | 681.47M | 671.96M | 746.27M | 682.26M | 764.04M | 866.29M | 885.84M | 860.22M |
| Operating Income | 88.46M | 62.37M | 45.82M | 76.27M | 85.43M | 66.78M | 63.75M | 79.89M | 71.55M | 50.40M | 103.14M | 63.64M | 80.53M | 98.46M | 82.88M | 98.27M | 82.43M | 88.77M | 89.08M | 82.41M | 73.75M | 87.47M | 102.22M | 71.57M | 95.24M | 79.88M | 101.88M | 87.84M | 86.67M | 85.36M | 123.19M | 92.96M | 98.81M | 96.58M | 92.26M | 96.63M | 102.42M | 113.35M | 92.06M | 106.69M |
| Net Income | 58.37M | 41.06M | 33.99M | 55.72M | 61.26M | 46.55M | -15.69M | 66.44M | 60.66M | 77.92M | 21.93M | 48.98M | 58.88M | 74.81M | 61.45M | 75.50M | 64.26M | 73.17M | 65.74M | 69.75M | 59.35M | 59.91M | 116.86M | 59.01M | 74.61M | 61.60M | 42.97M | 61.09M | 58.60M | 60.27M | 65.89M | 68.47M | 72.97M | 69.48M | 71.02M | 75.46M | 78.39M | 82.11M | 92.99M | 91.07M |
| Diluted EPS | 0.56 | 0.39 | 0.34 | 0.55 | 0.61 | 0.46 | -0.16 | 0.66 | 0.60 | 0.78 | 0.22 | 0.51 | 0.62 | 0.78 | 0.64 | 0.79 | 0.67 | 0.76 | 0.69 | 0.73 | 0.62 | 0.63 | 1.26 | 0.64 | 0.82 | 0.67 | 0.47 | 0.67 | 0.64 | 0.66 | 0.72 | 0.75 | 0.79 | 0.76 | 0.77 | 0.82 | 0.85 | 0.89 | 1.01 | 0.99 |
| R&D Expense | 1.57M | 1.75M | - | 1.52M | 1.15M | 2.60M | - | 3.61M | 4.11M | 3.96M | - | 5.17M | 5.33M | 5.12M | - | 4.60M | 4.03M | 2.93M | - | 3.12M | 3.50M | 2.87M | - | 2.95M | 2.61M | 1.43M | - | 2.20M | 2.60M | 1.16M | - | 1.49M | 1.27M | 2.08M | - | 2.01M | 4.57M | 3.48M | - | 4.10M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.69B | 2.95B | 3.29B | 1.55B | 1.45B | 1.42B | 1.55B | 1.69B | 1.80B | 1.89B | 2.12B | 2.12B | 2.23B | 2.50B | 2.70B | 3.20B |
| Operating Income | 248.85M | 95.67M | 346.59M | 306.91M | 25.12M | 205.94M | 234.43M | 292.22M | 304.98M | 325.52M | 358.55M | 345.85M | 348.57M | 383.06M | 380.61M | 404.46M |
| Net Income | 139.94M | 78.32M | 227.69M | 346.08M | 29.39M | 131.47M | 183.06M | 147.84M | 226.96M | 244.12M | 278.67M | 305.87M | 238.19M | 245.85M | 281.94M | 328.94M |
| Diluted EPS | 1.19 | 0.66 | 1.91 | 3.07 | 0.27 | 1.22 | 1.76 | 1.47 | 2.27 | 2.55 | 2.91 | 3.24 | 2.60 | 2.68 | 3.07 | 3.58 |
| R&D Expense | 69.17M | 106.40M | 120.56M | 58.18M | 54.75M | 10.54M | 6.41M | 7.19M | 15.22M | 17.67M | 14.19M | 11.06M | 9.54M | 7.61M | 7.48M | 13.87M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 2.50B | 2.79B | 2.84B | 2.61B | 2.86B | 1.38B | 1.58B | 1.71B | 1.66B | 1.91B | 2.29B | 2.50B | 2.62B | 2.75B | 2.87B | 4.27B |
| Total Equity | 120.71M | 713.52M | 825.79M | 986.43M | 1.16B | 998.70M | 265.72M | 150.02M | 285.39M | 235.66M | 404.11M | 617.77M | 637.17M | 748.31M | 933.35M | 1.08B | 1.23B |
| Cash & Equivalents | 469.47M | 391.14M | 415.21M | 383.55M | 346.12M | 123.62M | 154.73M | 125.64M | 203.40M | 29.87M | 86.54M | 42.61M | 33.89M | 35.24M | 75.77M | 74.11M | 499.78M |
| Long Term Debt | - | - | 633.00K | 430.00K | 225.00K | 285.00M | 278.26M | 497.72M | 481.06M | 753.62M | 809.44M | 862.73M | 1.19B | 1.28B | 1.20B | 1.04B | 2.02B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.79B | 3.04B |
| Current Liabilities | - | - | 1.15B | 1.08B | 927.23M | 819.64M | 353.78M | 439.88M | 528.13M | 377.35M | 404.71M | 529.73M | 459.62M | 367.86M | 375.05M | 474.20M | 672.02M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 192.41M | 173.59M | 184.93M | 137.89M | 74.92M | 335.16M | 239.91M | 221.96M | 169.29M | 279.37M | 196.44M | 386.03M | 244.70M | 363.70M | 408.43M | 479.85M |
| Investing Cash Flow | -90.31M | -154.32M | -111.40M | 20.05M | - | -71.89M | -188.92M | -89.68M | -326.72M | -180.00M | -265.32M | -304.65M | -256.24M | -155.64M | -154.56M | -742.11M |
| Financing Cash Flow | -183.73M | 7.54M | -108.01M | -190.88M | 104.60M | -414.42M | -88.90M | -61.18M | -9.32M | -43.71M | 25.05M | -90.14M | 13.95M | -169.37M | -252.78M | 693.64M |
| Capital Expenditure | -63.65M | -63.87M | -86.64M | -64.95M | -76.03M | -68.33M | -52.63M | -96.88M | -109.34M | -182.12M | -255.03M | -311.05M | -198.31M | -151.29M | -153.65M | -184.56M |
| Free Cash Flow | 128.76M | 109.72M | 98.29M | 72.94M | -1.10M | 266.82M | 187.27M | 125.08M | 59.95M | 97.24M | -58.59M | 74.97M | 46.39M | 212.41M | 254.78M | 295.29M |
| Share Buybacks | - | - | 96.77M | 157.09M | 149.77M | 69.75M | 293.00M | 0 | 214.76M | 20.00M | 21.96M | 225.79M | 20.00M | 0 | 20.00M | 30.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 9.3% | 3.2% | 10.5% | 19.8% | 1.7% | 14.5% | 15.1% | 17.3% | 16.9% | 17.2% | 16.9% | 16.3% | 15.6% | 15.3% | 14.1% | 12.6% |
| Net Margin % | 5.2% | 2.7% | 6.9% | 22.4% | 2.0% | 9.3% | 11.8% | 8.8% | 12.6% | 12.9% | 13.1% | 14.4% | 10.7% | 9.8% | 10.4% | 10.3% |
| ROE % | 19.6% | 9.5% | 23.1% | 29.7% | 2.9% | 49.5% | 122.0% | 51.8% | 96.3% | 60.4% | 45.1% | 48.0% | 31.8% | 26.3% | 26.1% | 26.7% |
| ROCE % | - | 5.9% | 19.7% | 18.2% | 1.2% | 20.2% | 20.6% | 24.7% | 23.9% | 21.6% | 20.3% | 16.9% | 15.5% | 16.1% | 15.9% | 11.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BWXT
BWX Technologies Stock (BWXT) Opinions on Earnings Growth and Nuclear Demand - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQWjBrMC1lOHhKRzBUMzIxQy1pMUhubnJZWGh1RUpPWktGV2dWZktLYTBBTjNKbk0wS1c0dXd2bkE5Y1Izc0RhZllHVXBObnJQU3ZBdVFWblNJQlpuTjVnRGR1d2kxQ3lTeGEzWmdlMm5kMGZSeXJFZWN0ZlZzLXRXRkk0MFpzR1BmbXMzQW…
BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOSTA4R1RzUFloNGxnZmdtVVI2dTNZVjR3ZXIyV2JXSXFBcDkxbFQxMHE4ZWZlN3VFVVJYNlJGeWl2MkpXanBHUGdmNjFOVzBHaEh4WTBTTGliQ0t2VU9GNl9Xd1dKV3N6cU1KMEhvTzJhZ0JIR2ZTQ1Ytcnhfem9oOG9hY1lQNjFqbUVBRT…
BWX Technologies (BWXT) Stock Price Lags Backlog Surge and Premium P E - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxNdEtEelVUeHQxN2NBbEp1OXkyb3ZBYjhFbUxscjUxSzJ5SmlBa010YTF0RzhEU21zUE10WlhieFdQTDZ0SmZKTnhDZGVWaFRtTGJDOEVjWllmeUlJSVlrUjZ4dVl2ZmpiU2NnX1ZtMFQ5ckVXWDUtRTkwMEVhTEMyQVNYVGlKRUllNEplLX…
BWX Technologies: Solid Performance, Interesting M&A Efforts (NYSE:BWXT) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPc19xVFhRd25FVzdIeWRkVk5HNTVsTE1UYk85WHpWV0VVc0x4WXRkWjQzS2pZNWMzUVJ2TDdCN05fYnY2eHdWUnFldzFFRTJabXY1QUowNjdzUFJwNUlHZ3ZIMWRpdlhMNUp6S3lXWWZaeENjT25ycW1YVFM3dkZ2ZDFFOWJlOUFJdEtkNH…
BWX Technologies (BWXT) Stock Could Be 21% Overvalued On Nuclear Cash Flow Hopes - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNNlotclpIOS1JSmNOYU9BdjBSSDkwQjh4WWFuOHgwOExaRm9jNE5JMHFRc21mblRlV2pXLVdYRzVpUlpTLTVKd2xIb2VWeFp3NFBHNlcwUS1aZVhGVkdNY0VwWlkwZmlqSTFqYW15M3Z3emNOQjVQbE5QVFN6TF9RbDhxcDQzXy1pZUJHSU…
BWX Technologies Announces Medical Sale to Focus on Nuclear Markets - Stock Titan
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQZTdHVmQ5MGR2cUM3d1Jfb1E5ci0zcXFvTXN4V3JabWF4aTRfazVSVmFpbjduQmtTeUJVeFFscmktTTRMQTFHalB3UEltS2ZkM3ExMlE2NURzRXRTNm9fbDd5dG93Yk9wOTN2SFUtRHd2a0VzQmdwWFhrOF9lWGFHZElHbDdvbzZtZVVmNF…
BWXT — Frequently Asked Questions
What is the current share price of BWXT?
As of 2026-08-05 17:25 PDT, BWXT trades at $168.28 on NASDAQ/NYSE. Its 52-week range is $153.65 to $238.10.
What is the P/E ratio of BWXT?
BWXT trades at a trailing price-to-earnings (P/E) ratio of 47.01.
What is the return on equity (ROE) of BWXT?
BWXT has a return on equity (ROE) of 26.69%. Its return on capital employed (ROCE) is 11.24%.
Is BWXT a good stock to buy?
This page provides a data-driven analysis of BWXT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.